The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease

Molecular Medicine Reports

Volumn 5, Issue 4, 2012, Pages 1111-1115

  Portelius, Erik ^a   Fortea, Juan ^b   Molinuevo, Jose Luis ^b   Gustavsson, Mikael K ^a   Andreasson, Ulf ^a   Sanchez Valle, Raquel ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Amyloid isoforms; Familial Alzheimer's; Mass spectrometry; Presenilin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-13]; AMYLOID BETA PROTEIN[1-14]; AMYLOID BETA PROTEIN[1-15]; AMYLOID BETA PROTEIN[1-16]; AMYLOID BETA PROTEIN[1-17]; AMYLOID BETA PROTEIN[1-18]; AMYLOID BETA PROTEIN[1-19]; AMYLOID BETA PROTEIN[1-20]; AMYLOID BETA PROTEIN[1-30]; AMYLOID BETA PROTEIN[1-33]; AMYLOID BETA PROTEIN[1-34]; AMYLOID BETA PROTEIN[1-37]; AMYLOID BETA PROTEIN[1-38]; AMYLOID BETA PROTEIN[1-39]; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GAMMA SECRETASE; PRESENILIN 1; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; GENE MUTATION; HUMAN;

ADULT; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; HUMANS; IMMUNOPRECIPITATION; MUTATION; PEPTIDE FRAGMENTS; PRESENILIN-1; PROTEIN ISOFORMS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84858259539     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.774     Document Type: Article

References (25)

1. Hardy JA and Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185, 1992.
2. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC and Selkoe DJ: Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3: 16-32, 1996.
3. Rovelet-Lecrux A, Hannequin D, Raux G, et al: APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38: 24-26, 2006. (Pubitemid 43011878)
4. Beher D, Wrigley JD, Owens AP and Shearman MS: Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity. J Neurochem 82: 563-575, 2002. (Pubitemid 34835674)
5. Portelius E, Price E, Brinkmalm G, et al: A novel pathway for amyloid precursor protein processing. Neurobiol Aging 32: 1090-1098, 2011.
6. Portelius E, Zetterberg H, Andreasson U, et al: An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid. Neurosci Lett 409: 215-219, 2006. (Pubitemid 44648565)
7. Portelius E, Andreasson U, Ringman JM, et al: Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease. Mol Neurodegener 5: 2, 2010.
8. Portelius E, Van Broeck B, Andreasson U, et al: Acute effect on the Abeta isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs. J Alzheimers Dis 21: 1005-1012, 2010.
9. Portelius E, Zhang B, Gustavsson MK, et al: Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease. Neurodegener Dis 6: 258-262, 2009.
10. Portelius E, Dean RA, Gustavsson MK, et al: A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease. Alzheimers Res Ther 2: 7, 2010.
11. Cook JJ, Wildsmith KR, Gilberto DB, et al: Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta rebound. J Neurosci 30: 6743-6750, 2010.
12. Goate A, Chartier-Harlin MC, Mullan M, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706, 1991. (Pubitemid 21912142)
13. Levy-Lahad E, Wasco W, Poorkaj P, et al: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977, 1995.
14. Sherrington R, Rogaev EI, Liang Y, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760, 1995.
15. Bentahir M, Nyabi O, Verhamme J, et al: Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 96: 732-742, 2006.
16. Citron M, Westaway D, Xia W, et al: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3: 67-72, 1997. (Pubitemid 27019143)
17. Kumar-Singh S, Theuns J, Van Broeck B, et al: Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum Mutat 27: 686-695, 2006.
18. Ringman JM, Younkin SG, Pratico D, et al: Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology 71: 85-92, 2008.
19. Fortea J, Llado A, Clarimon J, et al: PICOGEN: Five years experience with a genetic counselling program for dementia. Neurologia 26: 143-149, 2011.
20. Sanchez-Valle R, Llado A, Ezquerra M, Rey MJ, Rami L and Molinuevo JL: A novel mutation in the PSEN1 gene (L286P) associated with familial early-onset dementia of Alzheimer type and lobar haematomas. Eur J Neurol 14: 1409-1412, 2007. (Pubitemid 350135311)
21. Fortea J, Llado A, Bosch B, et al: Cerebrospinal fluid biomarkers in Alzheimer's disease families with PSEN1 mutations. Neurodegener Dis 8: 202-207, 2011.
22. Portelius E, Tran AJ, Andreasson U, et al: Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. J Proteome Res 6: 4433-4439, 2007. (Pubitemid 350158518)
23. Blennow K, Hampel H, Weiner M and Zetterberg H: Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6: 131-144, 2010.
24. Andreasson U, Portelius E, Andersson ME, Blennow K and Zetterberg H: Aspects of beta-amyloid as a biomarker for Alzheimer's disease. Biomark Med 1: 59-78, 2007.
25. Portelius E, Bogdanovic N, Gustavsson MK, et al: Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease. Acta Neuropathol 120: 185-193, 2010.